FDA: Majority of applicants complied with postmarketing requirements, commitments
Regulatory NewsJoanne S. Eglovitch
Approval/marketing authorizationBiologics/ biosimilars/ vaccinesCBERCDERCompliancePharmaceuticalsPharmacovigilancePharmacovigilance/postmarket surveillanceProduct LifecycleRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)